Fibroblast growth factor 2 reduces endoplasmic reticulum stress and apoptosis in in-vitro Non-Alcoholic Fatty Liver Disease model

Seyedeh Parisa Hosseini,Shirin Farivar,Ramazan Rezaei,Samaneh Tokhanbigli,Behzad Hatami,Mohammad Reza Zali,Kaveh Baghaei
DOI: https://doi.org/10.1007/s40199-023-00459-x
2023-05-09
Abstract:Non-Alcoholic fatty liver disease is characterized by the accumulation of excess fat in the liver, chronic inflammation, and cell death, ranging from simple steatosis to fibrosis, and finally leads to cirrhosis and hepatocellular carcinoma. The effect of Fibroblast growth factor 2 on apoptosis and ER stress inhibition has been investigated in many studies. In this study, we aimed to investigate the effect of FGF2 on the NAFLD in-vitro model in the HepG2 cell line.
pharmacology & pharmacy
What problem does this paper attempt to address?